|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-5-17
|
|
pubmed:abstractText |
The calcipotriol/betamethasone dipropionate two-compound product Dovobet/Daivobet/Taclonex(LEO Pharma A/S, Ballerup, Denmark) has been shown to be safe and effective in the treatment of psoriasis for up to 8 weeks. As psoriasis is a chronic disease, long-term treatment may be required, so there is a need to investigate the safety of its use over a longer period of time.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
pubmed-author:AustadJJ,
pubmed-author:BarnesLL,
pubmed-author:BibbyAA,
pubmed-author:CambazardFF,
pubmed-author:FlemingCC,
pubmed-author:HeikkiläHH,
pubmed-author:JolliffeDD,
pubmed-author:KragballeKK,
pubmed-author:PeyriJJ,
pubmed-author:SvenssonAA,
pubmed-author:TooleJJ,
pubmed-author:WozelGG,
pubmed-author:de la BrassinneMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
154
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1155-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16704648-Adult,
pubmed-meshheading:16704648-Betamethasone,
pubmed-meshheading:16704648-Calcitriol,
pubmed-meshheading:16704648-Dermatologic Agents,
pubmed-meshheading:16704648-Double-Blind Method,
pubmed-meshheading:16704648-Drug Administration Schedule,
pubmed-meshheading:16704648-Drug Combinations,
pubmed-meshheading:16704648-Drug Eruptions,
pubmed-meshheading:16704648-Female,
pubmed-meshheading:16704648-Humans,
pubmed-meshheading:16704648-Male,
pubmed-meshheading:16704648-Middle Aged,
pubmed-meshheading:16704648-Psoriasis,
pubmed-meshheading:16704648-Severity of Illness Index
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
|
|
pubmed:affiliation |
Marselisborg Hospital, Aarhus, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
